TP53 and ovarian cancer: As TP53 mutation represents the driver mutation in more than 95% of the high grade serous cancers, but is very uncommon in type 1 ovarian cancers 5, 7, we wanted to explore how far the members of the miR-34 family are involved in the carcinogenesis and biology of ovarian cancer.